{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:13:56Z","timestamp":1789020836038,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":42,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["18K07544"],"award-info":[{"award-number":["18K07544"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000223","name":"Muscular Dystrophy Canada","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1074\/mcp.ra120.002345","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T19:56:11Z","timestamp":1601409371000},"page":"2047-2068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy"],"prefix":"10.1016","volume":"19","author":[{"given":"Tirsa L.E.","family":"van Westering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik J.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.L.","family":"Coenen-Stass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Lomonosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tanihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Motohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin'ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Lehti\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"EL Andaloussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3313-7631","authenticated-orcid":false,"given":"Thomas C.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.RA120.002345_bib1","first-page":"83","article-title":"Autopsy analyses of the muscular dystrophies","volume":"40","author":"Moriuchi","year":"1993","journal-title":"Tokushima J. Exp. Med"},{"key":"10.1074\/mcp.RA120.002345_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.amjcard.2016.01.031","article-title":"Relation of cardiac dysfunction to rhythm abnormalities in patients with Duchenne or Becker muscular dystrophies","volume":"117","author":"Chiang","year":"2016","journal-title":"Am. J. Cardiol"},{"key":"10.1074\/mcp.RA120.002345_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nmd.2010.09.006","article-title":"Duchenne muscular dystrophy: Survival by cardio-respiratory interventions","volume":"21","author":"Ishikawa","year":"2011","journal-title":"Neuromuscul. Disord"},{"key":"10.1074\/mcp.RA120.002345_bib4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jnnp-2012-303902","article-title":"Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy","volume":"84","author":"Ricotti","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1074\/mcp.RA120.002345_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mus.20586","article-title":"Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule","volume":"34","author":"Aartsma-Rus","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1074\/mcp.RA120.002345_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD global database: Analysis of more than 7,000 duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat"},{"key":"10.1074\/mcp.RA120.002345_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1074\/mcp.RA120.002345_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-5793(90)80728-2","article-title":"The interaction of actin with dystrophin","volume":"263","author":"Levine","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1074\/mcp.RA120.002345_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/mus.880130605","article-title":"Immunocytochemical study of dystrophin at the myotendinous junction","volume":"13","author":"Samitt","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1074\/mcp.RA120.002345_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: One gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet. Neurol"},{"key":"10.1074\/mcp.RA120.002345_bib11","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/molecules20058823","article-title":"Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy","volume":"20","author":"van Westering","year":"2015","journal-title":"Molecules"},{"key":"10.1074\/mcp.RA120.002345_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-510X(94)00276-T","article-title":"mdx mice show progressive weakness and muscle deterioration with age","volume":"129","author":"Pastoret","year":"1995","journal-title":"J. Neurol. Sci"},{"key":"10.1074\/mcp.RA120.002345_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.expneurol.2005.11.021","article-title":"Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice","volume":"198","author":"Messina","year":"2006","journal-title":"Exp. Neurol"},{"key":"10.1074\/mcp.RA120.002345_bib14","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1242\/jcs.03000","article-title":"Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration","volume":"119","author":"Yokota","year":"2006","journal-title":"J. Cell Sci"},{"key":"10.1074\/mcp.RA120.002345_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12981-5","article-title":"Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy","volume":"7","author":"Doorenweerd","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/mcp.RA120.002345_bib16","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/4.9.1475","article-title":"Cloning and characterization of alternatively spliced isoforms of Dp71","volume":"4","author":"Austin","year":"1995","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.RA120.002345_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/hmg\/4.5.837","article-title":"A novel dystrophin isoform is required for normal retinal electrophysiology","volume":"4","author":"D'Souza","year":"1995","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.RA120.002345_bib18","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1093\/hmg\/ddp320","article-title":"Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression","volume":"18","author":"Daoud","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.RA120.002345_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.ejhg.5200488","article-title":"Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening","volume":"8","author":"Moizard","year":"2000","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"10.1074\/mcp.RA120.002345_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis. Model. Mech"},{"key":"10.1074\/mcp.RA120.002345_bib21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1074\/mcp.RA120.002345_bib22","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: a point mutation","volume":"244","author":"Sicinski","year":"1989","journal-title":"Science"},{"key":"10.1074\/mcp.RA120.002345_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13395-015-0041-y","article-title":"Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia","volume":"5","author":"Duddy","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1074\/mcp.RA120.002345_bib24","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fj.06-7353com","article-title":"Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma","volume":"21","author":"Chamberlain","year":"2007","journal-title":"FASEB J. Off"},{"key":"10.1074\/mcp.RA120.002345_bib25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/mus.880070903","article-title":"Muscle development in mdx mutant mice","volume":"7","author":"Dangain","year":"1984","journal-title":"Muscle Nerve"},{"key":"10.1074\/mcp.RA120.002345_bib26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2164-6-98","article-title":"Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling","volume":"6","author":"Turk","year":"2005","journal-title":"BMC Genomics"},{"key":"10.1074\/mcp.RA120.002345_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-003-0773-3","article-title":"Longitudinal pathologic study of the gastrocnemius muscle group in mdx mice","volume":"107","author":"Roig","year":"2004","journal-title":"Acta Neuropathol.)"},{"key":"10.1074\/mcp.RA120.002345_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ar.1092420109","article-title":"Phenotype of dystrophinopathy in old mdx mice","volume":"242","author":"Lefaucheur","year":"1995","journal-title":"Anat. Rec"},{"key":"10.1074\/mcp.RA120.002345_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028569","article-title":"In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy","volume":"7","author":"Stuckey","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1074\/mcp.RA120.002345_bib30","unstructured":"The UMD-TREAT-NMD DMD Locus Specific Databases The UMD TREAT-NMD DMD mutations database."},{"key":"10.1074\/mcp.RA120.002345_bib31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/bbrc.1997.7328","article-title":"Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy","volume":"238","author":"Araki","year":"1997","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/mcp.RA120.002345_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069194","article-title":"Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice","volume":"8","author":"Echigoya","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1074\/mcp.RA120.002345_bib33","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1038\/mtna.2014.76","article-title":"Long-term efficacy of systemic multiexon skipping targeting Dystrophin exons 45-55 with a cocktail of vivo-morpholinos in Mdx52 mice","volume":"4","author":"Echigoya","year":"2015","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1074\/mcp.RA120.002345_bib34","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.ymthe.2017.07.014","article-title":"Quantitative antisense screening and optimization for exon 51 skipping in Duchenne muscular dystrophy","volume":"25","author":"Echigoya","year":"2017","journal-title":"Mol. Ther. J"},{"key":"10.1074\/mcp.RA120.002345_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-7374-3_9","article-title":"Exon skipping therapy using phosphorodiamidate morpholino oligomers in the mdx52 mouse model of Duchenne muscular dystrophy","volume":"1687","author":"Miyatake","year":"2018","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"10.1074\/mcp.RA120.002345_bib36","doi-asserted-by":"crossref","first-page":"15000","DOI":"10.1073\/pnas.192571199","article-title":"Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle","volume":"99","author":"Haslett","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1074\/mcp.RA120.002345_bib37","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4238\/2014.February.28.13","article-title":"Gene expression profiling of Duchenne muscular dystrophy reveals characteristics along disease progression","volume":"13","author":"Tian","year":"2014","journal-title":"Genet. Mol. Res"},{"key":"10.1074\/mcp.RA120.002345_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194485","article-title":"Expression profiling of disease progression in canine model of Duchenne muscular dystrophy","volume":"13","author":"Brinkmeyer-Langford","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1074\/mcp.RA120.002345_bib39","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1093\/hmg\/ddv381","article-title":"Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration","volume":"24","author":"Roberts","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.RA120.002345_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2217\/14622416.7.3.281","article-title":"Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy","volume":"7","author":"'t Hoen","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1074\/mcp.RA120.002345_bib41","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/MCB.19.3.1720","article-title":"Correlation between protein and mRNA abundance in yeast","volume":"19","author":"Gygi","year":"1999","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/mcp.RA120.002345_bib42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbrc.2005.11.055","article-title":"Correlation between mRNA and protein abundance in Desulfovibrio vulgaris: A multiple regression to identify sources of variations","volume":"339","author":"Nie","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/mcp.RA120.002345_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1152\/physiolgenomics.90370.2008","article-title":"Muscle genome-wide expression profiling during disease evolution in mdx mice","volume":"37","author":"Marotta","year":"2009","journal-title":"Physiol. Genomics"},{"key":"10.1074\/mcp.RA120.002345_bib44","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00421-011-1906-3","article-title":"Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice","volume":"111","author":"Gardan-Salmon","year":"2011","journal-title":"Eur. J. Appl. Physiol"},{"key":"10.1074\/mcp.RA120.002345_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/691641","article-title":"Profiling of age-related changes in the tibialis anterior muscle proteome of the mdx mouse model of dystrophinopathy","volume":"2012","author":"Carberry","year":"2012","journal-title":"J. Biomed. Biotechnol"},{"key":"10.1074\/mcp.RA120.002345_bib46","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1021\/pr2001385","article-title":"Quantitative proteomic analysis of dystrophic dog muscle","volume":"10","author":"Guevel","year":"2011","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.RA120.002345_bib47","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1074\/mcp.M112.023127","article-title":"Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse","volume":"12","author":"Rayavarapu","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA120.002345_bib48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jcsm.12527","article-title":"Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients","volume":"11","author":"Capitanio","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1074\/mcp.RA120.002345_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2044-5040-1-6","article-title":"Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques","volume":"1","author":"Ohlendieck","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1074\/mcp.RA120.002345_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10974-019-09507-z","article-title":"Proteomic profiling of the mouse diaphragm and refined mass spectrometric analysis of the dystrophic phenotype","volume":"40","author":"Murphy","year":"2019","journal-title":"J. Muscle Res. Cell Motil"},{"key":"10.1074\/mcp.RA120.002345_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1480-9222-16-5","article-title":"Detection and quantification of extracellular microRNAs in murine biofluids","volume":"16","author":"Roberts","year":"2014","journal-title":"Biol. Proced. Online"},{"key":"10.1074\/mcp.RA120.002345_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089237","article-title":"Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine Serum","volume":"9","author":"Roberts","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1074\/mcp.RA120.002345_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nmeth.2732","article-title":"HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics","volume":"11","author":"Branca","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.RA120.002345_bib54","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"Saeed","year":"2003","journal-title":"BioTechniques"},{"key":"10.1074\/mcp.RA120.002345_bib55","doi-asserted-by":"crossref","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene Suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.RA120.002345_bib56","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1038\/mtna.2012.26","article-title":"Expression analysis in multiple muscle groups and serum reveals complexity in the MicroRNA transcriptome of the mdx mouse with implications for therapy","volume":"1","author":"Roberts","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1074\/mcp.RA120.002345_bib57","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1093\/nar\/gkt724","article-title":"Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover","volume":"41","author":"Roberts","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.RA120.002345_bib58","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1093\/hmg\/ddw237","article-title":"Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation","volume":"25","author":"Coenen-Stass","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.RA120.002345_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018388","article-title":"Identification of muscle-specific MicroRNAs in serum of muscular dystrophy animal models: Promising novel blood-based markers for muscular dystrophy","volume":"6","author":"Mizuno","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1074\/mcp.RA120.002345_bib60","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201100133","article-title":"miRNAs as serum biomarkers for Duchenne muscular dystrophy","volume":"3","author":"Cacchiarelli","year":"2011","journal-title":"EMBO Mol. Med"},{"key":"10.1074\/mcp.RA120.002345_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2018.08.005","article-title":"Comprehensive RNA-sequencing analysis in serum and muscle reveals novel small RNA signatures with biomarker potential for DMD","volume":"13","author":"Coenen-Stass","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1074\/mcp.RA120.002345_bib62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.molmed.2017.09.002","article-title":"Biomarker potential of extracellular miRNAs in Duchenne muscular dystrophy","volume":"23","author":"Coenen-Stass","year":"2017","journal-title":"Trends Mol. Med"},{"key":"10.1074\/mcp.RA120.002345_bib63","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/hmg\/dds082","article-title":"Rescue of severely affected dystrophin\/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping","volume":"21","author":"Goyenvalle","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.RA120.002345_bib64","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1083\/jcb.115.6.1685","article-title":"Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice","volume":"115","author":"Ohlendieck","year":"1991","journal-title":"J. Cell Biol"},{"key":"10.1074\/mcp.RA120.002345_bib65","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/345315a0","article-title":"Deficiency of glycoprotein component of the dystrophin complex in dystrophic muscle Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle","volume":"345","author":"Ervasti","year":"1990","journal-title":"Nature"},{"key":"10.1074\/mcp.RA120.002345_bib66","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jcph.468","article-title":"Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers","volume":"55","author":"Tinsley","year":"2015","journal-title":"J. Clin. Pharmacol"},{"key":"10.1074\/mcp.RA120.002345_bib67","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/ncb2868","article-title":"The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter","volume":"15","author":"Pan","year":"2013","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/mcp.RA120.002345_bib68","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/hmg\/ddl083","article-title":"Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy","volume":"15","author":"Kleopa","year":"2006","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.RA120.002345_bib69","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1083\/jcb.115.6.1695","volume":"115","author":"Nguyen","year":"1991","journal-title":"J. Cell Biol"},{"key":"10.1074\/mcp.RA120.002345_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01486-4","article-title":"Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches","volume":"8","author":"Mariot","year":"2017","journal-title":"Nat. Commun"},{"key":"10.1074\/mcp.RA120.002345_bib71","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.59.3.431","article-title":"Reduced aquaporin 4 expression in the muscle plasma membrane of patients with Duchenne muscular dystrophy","volume":"59","author":"Wakayama","year":"2002","journal-title":"Arch. Neurol"},{"key":"10.1074\/mcp.RA120.002345_bib72","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/pmic.201400471","article-title":"Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis","volume":"15","author":"Holland","year":"2015","journal-title":"Proteomics"},{"key":"10.1074\/mcp.RA120.002345_bib73","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10974-017-9478-4","article-title":"Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin","volume":"38","author":"Murphy","year":"2017","journal-title":"J. Muscle Res. Cell Motil"},{"key":"10.1074\/mcp.RA120.002345_bib74","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nn.2160","article-title":"Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation","volume":"11","author":"Sato","year":"2008","journal-title":"Nat. Neurosci"},{"key":"10.1074\/mcp.RA120.002345_bib75","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/284470a0","article-title":"A role for collagen in the pathogenesis of muscular dystrophy?","volume":"284","author":"Duance","year":"1980","journal-title":"Nature"},{"key":"10.1074\/mcp.RA120.002345_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00687043","article-title":"Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse","volume":"69","author":"Tanabe","year":"1986","journal-title":"Acta Neuropathol.)"},{"key":"10.1074\/mcp.RA120.002345_bib77","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/mtna.2012.30","article-title":"Pip6-PMO, a new generation of peptide-oligonucleotide conjugates with improved cardiac exon skipping activity for DMD treatment","volume":"1","author":"Betts","year":"2012","journal-title":"Mol. Ther. \u2014 Nucleic Acids"},{"key":"10.1074\/mcp.RA120.002345_bib78","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1111\/febs.12267","article-title":"The mdx mouse model as a surrogate for Duchenne muscular dystrophy","volume":"280","author":"Partridge","year":"2013","journal-title":"FEBS J"},{"key":"10.1074\/mcp.RA120.002345_bib79","doi-asserted-by":"crossref","first-page":"11317","DOI":"10.3390\/molecules200611317","article-title":"Comparative label-free mass spectrometric analysis of mildly versus severely affected mdx mouse skeletal muscles identifies annexin, lamin, and vimentin as universal dystrophic markers","volume":"20","author":"Holland","year":"2015","journal-title":"Molecules"},{"key":"10.1074\/mcp.RA120.002345_bib80","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/hmg\/dds415","article-title":"Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition","volume":"22","author":"Percival","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.RA120.002345_bib81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mito.2018.02.006","article-title":"PPAR\u03b4 modulation rescues mitochondrial fatty acid oxidation defects in the mdx model of muscular dystrophy","volume":"46","author":"Bell","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1074\/mcp.RA120.002345_bib82","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","article-title":"Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1alpha","volume":"26","author":"Gerhart-Hines","year":"2007","journal-title":"EMBO J"},{"key":"10.1074\/mcp.RA120.002345_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1","volume":"434","author":"Rodgers","year":"2005","journal-title":"Nature"},{"key":"10.1074\/mcp.RA120.002345_bib84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/hmg\/11.3.263","article-title":"A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice","volume":"11","author":"Porter","year":"2002","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.RA120.002345_bib85","first-page":"5419","article-title":"IFN\u03b3 promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation","volume":"187","author":"Villalta","year":"2011","journal-title":"J. Immunol. Baltim. Md 1950"},{"key":"10.1074\/mcp.RA120.002345_bib86","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/01.WNL.0000049913.27181.51","article-title":"Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy","volume":"60","author":"Monici","year":"2003","journal-title":"Neurology"},{"key":"10.1074\/mcp.RA120.002345_bib87","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1172\/JCI30556","article-title":"Interplay of IKK\/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy","volume":"117","author":"Acharyya","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1074\/mcp.RA120.002345_bib88","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1126\/science.1099962","article-title":"Oscillations in NF-kappaB signaling control the dynamics of gene expression","volume":"306","author":"Nelson","year":"2004","journal-title":"Science"},{"key":"10.1074\/mcp.RA120.002345_bib89","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","article-title":"Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders","volume":"25","author":"Kauppinen","year":"2013","journal-title":"Cell. Signal"},{"key":"10.1074\/mcp.RA120.002345_bib90","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cvr\/cvq080","article-title":"The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells","volume":"87","author":"Alvarez-Guardia","year":"2010","journal-title":"Cardiovasc. Res"},{"key":"10.1074\/mcp.RA120.002345_bib91","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cvr\/cvn327","article-title":"TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model","volume":"81","author":"Palomer","year":"2009","journal-title":"Cardiovasc. Res"},{"key":"10.1074\/mcp.RA120.002345_bib92","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jcp.20696","article-title":"Regulation of phosphatidylinositol 3-kinase (PI3K)\/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch","volume":"208","author":"Dogra","year":"2006","journal-title":"J. Cell. Physiol"},{"key":"10.1074\/mcp.RA120.002345_bib93","first-page":"267","article-title":"PI3 kinase regulation of skeletal muscle hypertrophy and atrophy","volume":"346","author":"Glass","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol"},{"key":"10.1074\/mcp.RA120.002345_bib94","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1074\/mcp.RA120.002345_bib95","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.97.7.3207","article-title":"Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B\/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells","volume":"97","author":"Persad","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1074\/mcp.RA120.002345_bib96","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00296-012-2657-0","article-title":"Resveratrol inhibits TNF-\u03b1-induced IL-1\u03b2, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase\/Akt pathway","volume":"33","author":"Tian","year":"2013","journal-title":"Rheumatol. Int"},{"key":"10.1074\/mcp.RA120.002345_bib97","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/nature05861","article-title":"Akt\/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator","volume":"447","author":"Li","year":"2007","journal-title":"Nature"},{"key":"10.1074\/mcp.RA120.002345_bib98","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1101\/gad.1525107","article-title":"PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy","volume":"21","author":"Handschin","year":"2007","journal-title":"Genes Dev"},{"key":"10.1074\/mcp.RA120.002345_bib99","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ajpath.2012.04.004","article-title":"AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm","volume":"181","author":"Pauly","year":"2012","journal-title":"Am. J. Pathol"},{"key":"10.1074\/mcp.RA120.002345_bib100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1124\/jpet.111.183210","article-title":"Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy","volume":"338","author":"Hori","year":"2011","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/mcp.RA120.002345_bib101","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90341","article-title":"Disease-modifying effects of orally bioavailable NF-\u03baB inhibitors in dystrophin-deficient muscle","volume":"1","author":"Hammers","year":"2016","journal-title":"JCI Insight"},{"key":"10.1074\/mcp.RA120.002345_bib102","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jcph.842","article-title":"A novel NF-\u03baB inhibitor, edasalonexent (CAT-1004), in development as a disease-modifying treatment for patients with Duchenne muscular dystrophy: phase 1 safety, pharmacokinetics, and pharmacodynamics in adult subjects","volume":"57","author":"Donovan","year":"2017","journal-title":"J. Clin. Pharmacol"},{"key":"10.1074\/mcp.RA120.002345_bib103","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1096\/fj.03-1024com","article-title":"Anti-TNF\u03b1 (Remicade\u00ae) therapy protects dystrophic skeletal muscle from necrosis","volume":"18","author":"Grounds","year":"2004","journal-title":"FASEB J"},{"key":"10.1074\/mcp.RA120.002345_bib104","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nmd.2014.04.006","article-title":"Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function","volume":"24","author":"Ermolova","year":"2014","journal-title":"Neuromuscul. Disord. NMD"},{"key":"10.1074\/mcp.RA120.002345_bib105","article-title":"Modulation of the vault protein-protein interaction for tuning of molecular release","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/mcp.RA120.002345_bib106","article-title":"Cell-surface major vault protein promotes cancer progression through harboring mesenchymal and intermediate circulating tumor cells in hepatocellular carcinomas","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/mcp.RA120.002345_bib107","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2006.06.076","article-title":"A novel human zinc finger protein ZNF540 interacts with MVP and inhibits transcriptional activities of the ERK signal pathway","volume":"347","author":"Xiang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/mcp.RA120.002345_bib108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cellsig.2015.10.007","article-title":"Major vault protein regulates cell growth\/survival signaling through oxidative modifications","volume":"28","author":"Das","year":"2016","journal-title":"Cell. Signal"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620600111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620600111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.RA120.002345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:07:22Z","timestamp":1761527242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620600111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":108,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1535947620600111"],"URL":"https:\/\/doi.org\/10.1074\/mcp.ra120.002345","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.RA120.002345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 van Westering et al.","name":"copyright","label":"Copyright"}]}}